Business Wire

CA-AMBARELLA

21.6.2021 11:02:09 CEST | Business Wire | Press release

Share
Ambarella Expands Security AI Vision SoC Portfolio With Two New Families; Doubles Resolution to 32MP30 for 4K Multi-Imager Cameras With Advanced AI

Ambarella, Inc. (NASDAQ: AMBA), an AI vision silicon company, today announced the expansion of its AI vision SoC portfolio with the new CV5S and CV52S security families. Based on the CVflow® architecture and advanced 5nm process technology, the new SoCs support simultaneous 4K encoding and advanced AI processing in a single low-power design, which provides industry-leading edge AI SoC performance per watt. The CV5S family is ideal for security camera applications that require multiple sensors for 360-degree coverage, over a wide area and with a long range, such as outdoor city environments or large buildings. The CV52S family is designed for single-sensor security cameras with advanced AI performance that need to more clearly identify individuals or objects in a scene, including faces and license plate numbers over long distances, such as ITS traffic cameras.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210621005178/en/

“Security system designers desire higher resolutions, increasing channel counts, and ever faster and more ubiquitous AI capabilities,” explained John Lorenz, senior technology & market analyst, computing at Yole Développement (Yole). “Ambarella’s newest AI vision SoCs for security, the CV5S and CV52S, are competitive solutions for meeting the growing demands of the security IC sector, which we forecast to exceed $4 billion by 2025, with two-thirds of that being chips with AI capabilities.” (1)

The new CV5S SoC family supports multi-imager camera designs and can simultaneously process and encode four imager channels of up to 8MP, or 4K resolution, each at 30 frames per second (fps), while performing advanced AI on each 4K imager. These SoCs double the encoding resolution and memory bandwidth while consuming 30% less power than Ambarella’s prior generation.

The new CV52S SoC family targets single-sensor security cameras and supports 4K resolution at 60fps, while providing 4x the AI computer vision performance, 2x the CPU performance and 50% more memory bandwidth than its predecessors. This increase in neural network (NN) performance enables more AI processing to be performed at the edge, instead of in the cloud.

“The global security industry is rapidly moving to higher 4K resolutions while increasing AI algorithm capabilities, to achieve better recognition of people and objects, along with multiple imagers for a wider field of view and longer range,” said Jerome Gigot, senior director of marketing, Ambarella. “Our new CV5S and CV52S security AI vision SoC families respectively support 4K multi-imager or high-frame-rate 4K single-imager designs with high performance edge AI processing, allowing the development of cameras that do not need to compromise between image resolution and AI processing accuracy.”

In addition to security, there are many other AIoT applications that can take advantage of the high resolution and advanced AI processing provided by these new SoC families. For example, smart cities can leverage high edge AI performance and image resolution for improved traffic management, accident detection and automated speed control, as well as the rapid location of missing and stolen vehicles. Likewise, smart retail operations can use this resolution and advanced AI to better manage product placement, adjust cashier staffing for real-time line management, enhance warehouse product tracking, and provide more actionable intelligence at both the store and corporate levels.

Additional features of the new CV5S and CV52S families include:

  • Robust SDK created specifically for the security camera market
  • CVflow tools that are compatible across all security families
  • Dual Arm® A76 1.6GHz CPUs with 1MB of L3 memory; a 2x performance gain over the prior generation for faster customer applications
  • Enhanced ISP with excellent HDR, ISO low-light, dewarping and rotation performance
  • On-chip privacy masking to block out a portion of the captured scene
  • New PCIe and USB 3.2 interfaces, enabling more complex, multi-chip security system designs than prior generation
  • Strong on-chip cybersecurity hardware to ensure secure IP cameras, including secure boot, OTP and Arm TrustZone technology
  • Multiple video inputs, with support for up to 14 cameras using MIPI virtual channels
  • SLVS-EC interface on the CV5S for reduced system design complexity
  • Support for LPDDR4x, LPDDR5 and LPDDR5x DRAM

Availability

The CV5S and CV52S SoC families are expected to be available for sampling in October. For more information, contact Ambarella: https://www.ambarella.com/contact-us/ .

About Ambarella

Ambarella’s products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving and robotics applications. Ambarella’s low-power systems on chip (SoCs) offer high-resolution video compression, advanced image processing and powerful deep neural network processing to enable intelligent cameras to extract valuable data from high-resolution video streams. For more information, please visit www.ambarella.com

All brand names, product names, or trademarks belong to their respective holders. Ambarella reserves the right to alter product and service offerings, specifications, and pricing at any time without notice. © 2021 Ambarella. All rights reserved.

1. Source: Cameras and computing for surveillance and security report , Yole Développement, 2020

Link:

ClickThru

Social Media:

https://www.facebook.com/ambarellacorp/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.

Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release

Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye